Welcome
Dear Colleagues,
We are excited to invite you to the 2nd edition of the Cardiometabolic, Renal, Liver, and Obesity Conference (CaReMeLO 2025), taking place in Warsaw, Poland, on 30-31 May 2025.
Following the tremendous success of the inaugural CaReMe-O conference in Spain in 2024, which saw over 1000 participants (250 onsite and 750 online), we are building on this momentum to further empower family physicians in the comprehensive management of cardiometabolic, renal, liver, and obesity conditions. This year, we are placing a greater emphasis on cutting-edge therapies, such as GLP-1 receptor agonists like Trizepatide and Wegovy, which are transforming obesity treatment.
The 2025 edition promises to deliver an even more dynamic and impactful experience, incorporating feedback from last year. Expect more interactive sessions, practical workshops, and enriched networking opportunities, as well as deeper explorations of the latest treatments and innovations in managing obesity and liver disease.
This conference is vital for family physicians, general practitioners, nurse practitioners, and specialists in endocrinology, cardiology, and nephrology. If you are involved in managing patients with cardiometabolic and obesity syndromes, this event is designed for you.
Join us in Warsaw to explore innovative strategies and strengthen your expertise in managing CaReMeLO syndromes. This is your opportunity to make a lasting impact on patient care and outcomes. Stay tuned for more details about this essential event for primary care providers and specialists.
We eagerly anticipate welcoming you to CaReMeLO 2025 in Warsaw!
On behalf of the Scientific Committee,
Prof. Avraham Karasik
Co-Chair of CaReMeLO, Professor of Medicine (Emeritus), Tel Aviv University, Israel
Prof. Dr. Josep Vilaseca
Co-Chair of CaReMeLO, General Practitioner/ Family Doctor, University of Vic – Central Catalonia University; Althaia Foundation, Spain
Prof. Karolina Kłoda
Co-Chair of CaReMeLO, Polish Society of Family Medicine (PTMR) and Polish Society for the Treatment of Obesity
Dr. Baruch Itzhak
Co-Chair of CaReMeLO, Specialist in Family Medicine, Diabetologist, Clalit Health Services, Technion Faculty of Medicine, Haifa, Israel
Prof. Dr. Agnieszka Mastalerz-Migas
Co-Chair of CaReMeLO, President of the Polish Society of Family Medicine (PTMR)
Prof. Dr. Hiddo Lambers Heerspink
Co-Chair of CaReMeLO, Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, the Netherlands
Dr. Aleksander Biesiada
Co-Chair of CaReMeLO, Vice-President, Polish Society of Family Medicine (PTMR)